U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT06918405) titled 'Efficacy and Safety of Tirzepatide for Weight Management' on April 02.
Brief Summary: The goal of this study is to learn if tirzepatide helps people manage their weight safely. It will include adults in Bangladesh who are overweight or obese, with or without type 2 diabetes. The main questions it aims to answer are:
Does tirzepatide help people lose weight?
What side effects do people experience while taking tirzepatide?
All participants will:
Receive tirzepatide as a weekly injection, starting at 2.5 mg and gradually increasing to 15 mg.
Continue the treatment for 52 weeks (12 months).
Visit the clinic for regular checkups a...